Welcome to our dedicated page for Pluri SEC filings (Ticker: PLUR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Pluri Inc. SEC filings document the governance, capital-structure, listing-status, and material-event disclosures of a biotechnology company using a proprietary cell-based platform. Proxy materials cover annual shareholder meeting matters, director elections, auditor ratification, and board governance.
Pluri’s Form 8-K filings record events such as board composition changes, executive equity awards, Nasdaq Capital Market listing-standard notices and compliance updates, material agreements, shareholder voting matters, and capital-structure disclosures. These filings provide the formal record for corporate actions affecting the company’s common shares, governance framework, and public-company reporting obligations.
Pluri Inc. director Doron Shorrer has filed an initial Form 3 reporting his beneficial ownership of the company’s common stock. The filing shows indirect ownership of 6,969 shares of Common Stock held "By Shorrer International Ltd." and direct ownership of 6,659 shares of Common Stock in his own name.
Pluri Inc. director and 10% owner Alexandre Weinstein reported routine equity compensation and a warrant expiration. He received 641 shares of Common Stock as a grant or award at no cost, bringing his directly held common shares to 6,925 following the transaction.
The filing notes he has been granted 10,769 restricted stock units (RSUs) under two equity compensation plans. As of the current date, 6,284 RSUs have vested, 641 RSUs are scheduled to vest within 60 days, and 3,844 RSUs remain unvested and subject to future vesting conditions.
Separately, 625,000 Common Warrants held indirectly through Chutzpah Holdings LP, each exercisable for one Common Share at an exercise price of $4.25 per share, expired on June 30, 2026 with no remaining position from that warrant grant.
Pluri Inc. major shareholder Alexandre Weinstein and his affiliated entities report updated ownership and warrant details in this amended Schedule 13D. As of June 30, 2026, the reporting group beneficially owns 4,352,641 Pluri common shares, calculated as approximately 38.01% of shares outstanding but contractually capped at 35% by a beneficial ownership blocker.
Chutzpah Holdings Ltd. holds 2,018,014 shares, including warrants for 84,599 shares. Chutzpah Holdings LP holds 1,875,000 shares, combining 1,250,000 common shares and warrants for 625,000 shares at $4.25 per share, subject to a 35% Beneficial Ownership Limitation. Plantae Bioscience Ltd. holds 452,702 shares, and Weinstein directly holds 6,925 shares including vested and near-term vesting RSUs. This amendment also notes the expiration of 625,000 earlier CHLP warrants on June 30, 2026 and summarizes key securities purchase and asset purchase agreements underpinning these positions.
Pluri Inc. entered into an Advance Subscription Agreement with Chutzpah Holdings LP, under which the investor paid an advance amount of $1,250,000 on June 16, 2026 for use as working capital and general corporate purposes. The amount is expected to be credited against securities the investor may purchase in a Board-approved financing to be consummated on or before August 14, 2026, subject to Nasdaq rules, corporate approvals and available authorized shares.
Following the 2026 annual meeting, director Eitan Ajchenbaum was not re-elected and left the Board, including his roles as Audit Committee chair and sole Investment Committee member. On June 19, 2026, the Board appointed company founder Doron Shorrer as a non-executive director, chairman of the Audit Committee, audit committee financial expert, and sole member of the Investment Committee. Shareholders also ratified Kesselman & Kesselman as Pluri’s independent registered public accounting firm for the fiscal year ending June 30, 2026.
Pluri Inc. is in ongoing discussions with the European Investment Bank (EIB) over its existing loan. The EIB finance agreement provides for up to €50 million, of which the first €20 million tranche was drawn in June 2021 at 4% interest and was scheduled to mature on June 1, 2026.
On May 28, 2026, the EIB told Pluri that the parties remain in constructive, good-faith negotiations to reach a mutually agreed resolution regarding this €20 million EIB Loan. The EIB indicated it does not currently contemplate enforcement actions while talks continue and expects discussions not to extend beyond July 3, 2026.
The EIB has reserved all rights and may act if negotiations do not lead to an outcome it finds acceptable. Pluri cautions that there is no assurance of a mutually acceptable resolution or continued forbearance, and highlights broader risks including its liquidity position and need for additional financing.
Pluri Inc. reported lower revenue and a deeper loss while facing significant liquidity pressure. Revenue for the nine months ended March 31, 2026 was $681,000, down from $938,000 a year earlier, mainly due to a lower volume of CDMO and AgTech projects. Net loss widened to $19,176,000 from $15,481,000, driven by higher R&D and general and administrative expenses, including added costs from subsidiaries and increased share-based compensation.
As of March 31, 2026, Pluri held $9,548,000 in cash, cash equivalents, restricted cash and short-term deposits, against a working capital deficit of $21,543,000 and an accumulated deficit of $460,996,000. A €20 million European Investment Bank loan, with a linked principal of $22,976,000 and accrued interest of $4,438,000, is due on June 1, 2026, and is classified as a current liability while restructuring talks continue.
The company raised equity through a private placement of 625,000 shares and matching warrants in each of a First and Second Offering at $4.00 per share and warrant, sales under a $10 million at-the-market agreement, and SAFE financings at subsidiary Kokomodo. Despite cost-cutting, management states it has resources to fund operations for less than three months from May 14, 2026 and concludes that substantial doubt exists about Pluri’s ability to continue as a going concern.
Pluri Inc. reported that insider-affiliated investor Chutzpah Holdings LP, which is beneficially owned by director and 10% owner Alexandre Weinstein, agreed to a private placement under a March 24, 2026 Securities Purchase Agreement. The deal covers 625,000 common shares and common warrants to purchase 625,000 common shares at a combined price of $4.00 per share and accompanying warrant.
The agreement closed in two tranches: on March 31, 2026 and April 21, 2026, CHLP acquired 312,500 common shares and common warrants to purchase 312,500 common shares at each closing, providing total gross proceeds of $2,500,000 to Pluri. The common warrants are exercisable immediately at $4.25 per share and expire 18 months after issuance, with a hard 35% beneficial ownership cap. The filing also details Weinstein’s indirect holdings through CHLP and related entities, as well as his vested and scheduled-to-vest restricted stock units.
Pluri Inc. investor group updates its ownership disclosure. Chutzpah Holdings Limited, Chutzpah Holdings LP (CHLP), Plantae Bioscience and Alexandre Weinstein now report aggregate beneficial ownership of 3,794,897 Pluri common shares, representing approximately 34.98% of the company’s outstanding stock.
CHL beneficially owns 2,018,014 shares, including 1,933,415 common shares and warrants for 84,599 shares. CHLP beneficially owns 1,317,897 shares, combining 1,250,000 common shares with 110,000 warrant shares counted under a 35% Beneficial Ownership Limitation. Plantae holds 452,702 shares. Mr. Weinstein’s total includes these indirect holdings plus 6,284 shares and RSUs held directly.
Pluri Inc. is asking shareholders to vote at its June 15, 2026 annual meeting in Haifa, Israel on two main items: electing five directors and ratifying Kesselman & Kesselman (a PwC member firm) as independent auditors for the year ending June 30, 2026.
The record date is April 23, 2026, when 10,774,666 common shares were outstanding, each with one vote. A quorum requires at least 33⅓% of voting power present. The proposed board slate includes Chairman Alexandre Weinstein and CEO Yaky Yanay.
The proxy details committee structures, director independence, and executive pay, including CEO total compensation of $1.50 million for fiscal 2025 and equity-heavy incentives. It also discloses a related-party Kokomodo acquisition, where a Pluri subsidiary bought approximately 79% of Kokomodo Ltd. from entities controlled by Chairman Weinstein for $4.5 million, paid in 976,139 Pluri shares, plus assignment of a $0.5 million convertible loan.